D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
851
DELISTED
Paramount Global Class B
PARA
| $12M | 0.02% |
854,591
+804,749
| +1,615% | +$23.1M |
|
852
Inogen
INGN
$167M
| $12M | 0.02% |
231,470
-133,193
| -37% | -$6.4M |
|
853
Brunswick
BC
$5.19B
| $11.9M | 0.02% |
337,570
-265,812
| -44% | -$14.1M |
|
854
Genworth Financial
GNW
$3.8B
| $11.9M | 0.02% |
3,594,055
+2,968,447
| +474% | +$12.3M |
|
855
Churchill Downs
CHDN
$6.03B
| $11.9M | 0.02% |
231,348
+157,328
| +213% | +$10.1M |
|
856
Exelixis
EXEL
$13.9B
| $11.9M | 0.02% |
690,097
-622,535
| -47% | -$11.4M |
|
857
Guidewire Software
GWRE
$11.5B
| $11.9M | 0.02% |
149,705
+143,390
| +2,271% | +$15M |
|
|
SAGE
858
DELISTED
Sage Therapeutics
SAGE
| $11.9M | 0.02% |
413,230
+336,537
| +439% | +$19.5M |
|
|
ALXN
859
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $11.8M | 0.02% |
131,900
+46,300
| +54% | +$4.54M |
|
860
News Corp Class A
NWSA
$14.5B
| $11.8M | 0.02% |
1,318,537
-302,787
| -19% | -$3.82M |
|
861
BlackBerry
BB
$5.01B
| $11.8M | 0.02% |
2,861,457
-93,978
| -3% | -$511K |
|
862
M&T Bank
MTB
$36.2B
| $11.8M | 0.02% |
114,104
-54,396
| -32% | -$8M |
|
863
CenterPoint Energy
CNP
$29.1B
| $11.8M | 0.02% |
762,783
+752,683
| +7,452% | +$17.3M |
|
864
CALL
Western Digital
WDC
$179B
| $11.8M | 0.02% |
374,277
+99,225
| +36% | +$4.39M |
|
865
PUT
CoStar Group
CSGP
$11.3B
| $11.7M | 0.02% |
+200,000
| New | +$13M |
|
866
CRISPR Therapeutics
CRSP
$4.58B
| $11.7M | 0.02% |
275,859
+267,192
| +3,083% | +$13.8M |
|
867
Bio-Techne
TECH
$11.2B
| $11.7M | 0.02% |
246,568
-59,208
| -19% | -$2.96M |
|
868
Amcor
AMCR
$20.6B
| $11.7M | 0.02% |
287,190
+160,282
| +126% | +$7.68M |
|
869
CALL
Hershey
HSY
$35.4B
| $11.6M | 0.02% |
87,900
-31,900
| -27% | -$4.71M |
|
870
HNI Corp
HNI
$3B
| $11.6M | 0.02% |
461,392
+32,209
| +8% | +$1.07M |
|
871
Sabra Healthcare REIT
SBRA
$5.64B
| $11.5M | 0.02% |
1,056,330
+987,068
| +1,425% | +$18.2M |
|
|
SPLK
872
PUT
DELISTED
Splunk Inc
SPLK
| $11.5M | 0.02% |
91,300
-30,800
| -25% | -$4.53M |
|
873
AptarGroup
ATR
$8.45B
| $11.5M | 0.02% |
115,523
+48,669
| +73% | +$5.28M |
|
874
PUT
Illumina
ILMN
$29.4B
| $11.5M | 0.02% |
43,279
+13,673
| +46% | +$3.82M |
|
875
Encompass Health
EHC
$11.2B
| $11.5M | 0.02% |
225,187
-236,931
| -51% | -$13.7M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.